Global Atropine Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
Summary
Atropine is a medication to treat certain types of nerve agent and pesticide poisonings as well as some types of slow heart rate and to decrease saliva production during surgery. It is typically given intravenously or by injection into a muscle. Eye drops are also available which are used to treat uveitis and early amblyopia. The intravenous solution usually begins working within a minute and lasts half an hour to an hour. Large doses may be required to treat some poisonings. Common side effects include a dry mouth, large pupils, urinary retention, constipation, and a fast heart rate. It should generally not be used in people with angle closure glaucoma. While there is no evidence that its use during pregnancy causes birth defects, it has not been well studied. It is likely safe during breastfeeding. It is an antimuscarinic (a type of anticholinergic) that works by inhibiting the parasympathetic nervous system. Atropine occurs naturally in a number of plants of the nightshade family including deadly nightshade, Jimson weed, and mandrake. It was first isolated in 1833. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. It is available as a generic medication and is not very expensive.
According to APO Research, The global Atropine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Atropine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Atropine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Atropine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Atropine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Atropine include C?PHARMA, RESONANCE LABORATORIES, ROLABO OUTSOURCING, Minsheng, CR Double-Crane, HENAN PURUI, Albany Molecular Research, Alchem International and SAURAV CHEMICALS, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Atropine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Atropine, also provides the sales of main regions and countries. Of the upcoming market potential for Atropine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Atropine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Atropine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Atropine sales, projected growth trends, production technology, application and end-user industry.
Atropine segment by Company
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Atropine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Atropine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Atropine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Atropine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Atropine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Atropine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Atropine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
Atropine is a medication to treat certain types of nerve agent and pesticide poisonings as well as some types of slow heart rate and to decrease saliva production during surgery. It is typically given intravenously or by injection into a muscle. Eye drops are also available which are used to treat uveitis and early amblyopia. The intravenous solution usually begins working within a minute and lasts half an hour to an hour. Large doses may be required to treat some poisonings. Common side effects include a dry mouth, large pupils, urinary retention, constipation, and a fast heart rate. It should generally not be used in people with angle closure glaucoma. While there is no evidence that its use during pregnancy causes birth defects, it has not been well studied. It is likely safe during breastfeeding. It is an antimuscarinic (a type of anticholinergic) that works by inhibiting the parasympathetic nervous system. Atropine occurs naturally in a number of plants of the nightshade family including deadly nightshade, Jimson weed, and mandrake. It was first isolated in 1833. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. It is available as a generic medication and is not very expensive.
According to APO Research, The global Atropine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Atropine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Atropine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Atropine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Atropine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Atropine include C?PHARMA, RESONANCE LABORATORIES, ROLABO OUTSOURCING, Minsheng, CR Double-Crane, HENAN PURUI, Albany Molecular Research, Alchem International and SAURAV CHEMICALS, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Atropine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Atropine, also provides the sales of main regions and countries. Of the upcoming market potential for Atropine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Atropine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Atropine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Atropine sales, projected growth trends, production technology, application and end-user industry.
Atropine segment by Company
- C?PHARMA
- RESONANCE LABORATORIES
- ROLABO OUTSOURCING
- Minsheng
- CR Double-Crane
- HENAN PURUI
- Albany Molecular Research
- Alchem International
- SAURAV CHEMICALS
- Katsura Chemical
- Hangzhou Vega
- Wuhan senwayer century
- Injection
- Drop
- Gel
- Gastrointestinal
- Ophthalmology
- Other
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Atropine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Atropine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Atropine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Atropine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Atropine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Atropine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Atropine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Atropine Market Size, 2019 VS 2023 VS 2030
1.3 Global Atropine Market Size Estimates and Forecasts (2019-2030)
1.4 Global Atropine Sales Estimates and Forecasts (2019-2030)
1.5 Global Atropine Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 GLOBAL ATROPINE MARKET DYNAMICS
2.1 Atropine Industry Trends
2.2 Atropine Industry Drivers
2.3 Atropine Industry Opportunities and Challenges
2.4 Atropine Industry Restraints
3 ATROPINE MARKET BY MANUFACTURERS
3.1 Global Atropine Revenue by Manufacturers (2019-2024)
3.2 Global Atropine Sales by Manufacturers (2019-2024)
3.3 Global Atropine Average Sales Price by Manufacturers (2019-2024)
3.4 Global Atropine Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Atropine Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Atropine Manufacturers, Product Type & Application
3.7 Global Atropine Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Atropine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Atropine Players Market Share by Revenue in 2023
3.8.3 2023 Atropine Tier 1, Tier 2, and Tier
4 ATROPINE MARKET BY TYPE
4.1 Atropine Type Introduction
4.1.1 Injection
4.1.2 Drop
4.1.3 Gel
4.2 Global Atropine Sales by Type
4.2.1 Global Atropine Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Atropine Sales by Type (2019-2030)
4.2.3 Global Atropine Sales Market Share by Type (2019-2030)
4.3 Global Atropine Revenue by Type
4.3.1 Global Atropine Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Atropine Revenue by Type (2019-2030)
4.3.3 Global Atropine Revenue Market Share by Type (2019-2030)
5 ATROPINE MARKET BY APPLICATION
5.1 Atropine Application Introduction
5.1.1 Gastrointestinal
5.1.2 Ophthalmology
5.1.3 Other
5.2 Global Atropine Sales by Application
5.2.1 Global Atropine Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Atropine Sales by Application (2019-2030)
5.2.3 Global Atropine Sales Market Share by Application (2019-2030)
5.3 Global Atropine Revenue by Application
5.3.1 Global Atropine Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Atropine Revenue by Application (2019-2030)
5.3.3 Global Atropine Revenue Market Share by Application (2019-2030)
6 GLOBAL ATROPINE SALES BY REGION
6.1 Global Atropine Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Atropine Sales by Region (2019-2030)
6.2.1 Global Atropine Sales by Region (2019-2024)
6.2.2 Global Atropine Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Atropine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Atropine Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Atropine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Atropine Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Atropine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Atropine Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Atropine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Atropine Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 GLOBAL ATROPINE REVENUE BY REGION
7.1 Global Atropine Revenue by Region
7.1.1 Global Atropine Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Atropine Revenue by Region (2019-2024)
7.1.3 Global Atropine Revenue by Region (2025-2030)
7.1.4 Global Atropine Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Atropine Revenue (2019-2030)
7.2.2 North America Atropine Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Atropine Revenue (2019-2030)
7.3.2 Europe Atropine Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Atropine Revenue (2019-2030)
7.4.2 Asia-Pacific Atropine Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Atropine Revenue (2019-2030)
7.5.2 LAMEA Atropine Revenue Share by Country: 2019 VS 2023 VS 2030
8 COMPANY PROFILES
8.1 C?PHARMA
8.1.1 C?PHARMA Comapny Information
8.1.2 C?PHARMA Business Overview
8.1.3 C?PHARMA Atropine Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 C?PHARMA Atropine Product Portfolio
8.1.5 C?PHARMA Recent Developments
8.2 RESONANCE LABORATORIES
8.2.1 RESONANCE LABORATORIES Comapny Information
8.2.2 RESONANCE LABORATORIES Business Overview
8.2.3 RESONANCE LABORATORIES Atropine Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 RESONANCE LABORATORIES Atropine Product Portfolio
8.2.5 RESONANCE LABORATORIES Recent Developments
8.3 ROLABO OUTSOURCING
8.3.1 ROLABO OUTSOURCING Comapny Information
8.3.2 ROLABO OUTSOURCING Business Overview
8.3.3 ROLABO OUTSOURCING Atropine Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 ROLABO OUTSOURCING Atropine Product Portfolio
8.3.5 ROLABO OUTSOURCING Recent Developments
8.4 Minsheng
8.4.1 Minsheng Comapny Information
8.4.2 Minsheng Business Overview
8.4.3 Minsheng Atropine Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 Minsheng Atropine Product Portfolio
8.4.5 Minsheng Recent Developments
8.5 CR Double-Crane
8.5.1 CR Double-Crane Comapny Information
8.5.2 CR Double-Crane Business Overview
8.5.3 CR Double-Crane Atropine Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 CR Double-Crane Atropine Product Portfolio
8.5.5 CR Double-Crane Recent Developments
8.6 HENAN PURUI
8.6.1 HENAN PURUI Comapny Information
8.6.2 HENAN PURUI Business Overview
8.6.3 HENAN PURUI Atropine Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 HENAN PURUI Atropine Product Portfolio
8.6.5 HENAN PURUI Recent Developments
8.7 Albany Molecular Research
8.7.1 Albany Molecular Research Comapny Information
8.7.2 Albany Molecular Research Business Overview
8.7.3 Albany Molecular Research Atropine Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 Albany Molecular Research Atropine Product Portfolio
8.7.5 Albany Molecular Research Recent Developments
8.8 Alchem International
8.8.1 Alchem International Comapny Information
8.8.2 Alchem International Business Overview
8.8.3 Alchem International Atropine Sales, Price, Revenue and Gross Margin (2019-2024)
8.8.4 Alchem International Atropine Product Portfolio
8.8.5 Alchem International Recent Developments
8.9 SAURAV CHEMICALS
8.9.1 SAURAV CHEMICALS Comapny Information
8.9.2 SAURAV CHEMICALS Business Overview
8.9.3 SAURAV CHEMICALS Atropine Sales, Price, Revenue and Gross Margin (2019-2024)
8.9.4 SAURAV CHEMICALS Atropine Product Portfolio
8.9.5 SAURAV CHEMICALS Recent Developments
8.10 Katsura Chemical
8.10.1 Katsura Chemical Comapny Information
8.10.2 Katsura Chemical Business Overview
8.10.3 Katsura Chemical Atropine Sales, Price, Revenue and Gross Margin (2019-2024)
8.10.4 Katsura Chemical Atropine Product Portfolio
8.10.5 Katsura Chemical Recent Developments
8.11 Hangzhou Vega
8.11.1 Hangzhou Vega Comapny Information
8.11.2 Hangzhou Vega Business Overview
8.11.3 Hangzhou Vega Atropine Sales, Price, Revenue and Gross Margin (2019-2024)
8.11.4 Hangzhou Vega Atropine Product Portfolio
8.11.5 Hangzhou Vega Recent Developments
8.12 Wuhan senwayer century
8.12.1 Wuhan senwayer century Comapny Information
8.12.2 Wuhan senwayer century Business Overview
8.12.3 Wuhan senwayer century Atropine Sales, Price, Revenue and Gross Margin (2019-2024)
8.12.4 Wuhan senwayer century Atropine Product Portfolio
8.12.5 Wuhan senwayer century Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Atropine Value Chain Analysis
9.1.1 Atropine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Atropine Production Mode & Process
9.2 Atropine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Atropine Distributors
9.2.3 Atropine Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
1.1 Product Definition
1.2 Global Atropine Market Size, 2019 VS 2023 VS 2030
1.3 Global Atropine Market Size Estimates and Forecasts (2019-2030)
1.4 Global Atropine Sales Estimates and Forecasts (2019-2030)
1.5 Global Atropine Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 GLOBAL ATROPINE MARKET DYNAMICS
2.1 Atropine Industry Trends
2.2 Atropine Industry Drivers
2.3 Atropine Industry Opportunities and Challenges
2.4 Atropine Industry Restraints
3 ATROPINE MARKET BY MANUFACTURERS
3.1 Global Atropine Revenue by Manufacturers (2019-2024)
3.2 Global Atropine Sales by Manufacturers (2019-2024)
3.3 Global Atropine Average Sales Price by Manufacturers (2019-2024)
3.4 Global Atropine Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Atropine Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Atropine Manufacturers, Product Type & Application
3.7 Global Atropine Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Atropine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Atropine Players Market Share by Revenue in 2023
3.8.3 2023 Atropine Tier 1, Tier 2, and Tier
4 ATROPINE MARKET BY TYPE
4.1 Atropine Type Introduction
4.1.1 Injection
4.1.2 Drop
4.1.3 Gel
4.2 Global Atropine Sales by Type
4.2.1 Global Atropine Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Atropine Sales by Type (2019-2030)
4.2.3 Global Atropine Sales Market Share by Type (2019-2030)
4.3 Global Atropine Revenue by Type
4.3.1 Global Atropine Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Atropine Revenue by Type (2019-2030)
4.3.3 Global Atropine Revenue Market Share by Type (2019-2030)
5 ATROPINE MARKET BY APPLICATION
5.1 Atropine Application Introduction
5.1.1 Gastrointestinal
5.1.2 Ophthalmology
5.1.3 Other
5.2 Global Atropine Sales by Application
5.2.1 Global Atropine Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Atropine Sales by Application (2019-2030)
5.2.3 Global Atropine Sales Market Share by Application (2019-2030)
5.3 Global Atropine Revenue by Application
5.3.1 Global Atropine Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Atropine Revenue by Application (2019-2030)
5.3.3 Global Atropine Revenue Market Share by Application (2019-2030)
6 GLOBAL ATROPINE SALES BY REGION
6.1 Global Atropine Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Atropine Sales by Region (2019-2030)
6.2.1 Global Atropine Sales by Region (2019-2024)
6.2.2 Global Atropine Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Atropine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Atropine Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Atropine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Atropine Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Atropine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Atropine Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Atropine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Atropine Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 GLOBAL ATROPINE REVENUE BY REGION
7.1 Global Atropine Revenue by Region
7.1.1 Global Atropine Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Atropine Revenue by Region (2019-2024)
7.1.3 Global Atropine Revenue by Region (2025-2030)
7.1.4 Global Atropine Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Atropine Revenue (2019-2030)
7.2.2 North America Atropine Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Atropine Revenue (2019-2030)
7.3.2 Europe Atropine Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Atropine Revenue (2019-2030)
7.4.2 Asia-Pacific Atropine Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Atropine Revenue (2019-2030)
7.5.2 LAMEA Atropine Revenue Share by Country: 2019 VS 2023 VS 2030
8 COMPANY PROFILES
8.1 C?PHARMA
8.1.1 C?PHARMA Comapny Information
8.1.2 C?PHARMA Business Overview
8.1.3 C?PHARMA Atropine Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 C?PHARMA Atropine Product Portfolio
8.1.5 C?PHARMA Recent Developments
8.2 RESONANCE LABORATORIES
8.2.1 RESONANCE LABORATORIES Comapny Information
8.2.2 RESONANCE LABORATORIES Business Overview
8.2.3 RESONANCE LABORATORIES Atropine Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 RESONANCE LABORATORIES Atropine Product Portfolio
8.2.5 RESONANCE LABORATORIES Recent Developments
8.3 ROLABO OUTSOURCING
8.3.1 ROLABO OUTSOURCING Comapny Information
8.3.2 ROLABO OUTSOURCING Business Overview
8.3.3 ROLABO OUTSOURCING Atropine Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 ROLABO OUTSOURCING Atropine Product Portfolio
8.3.5 ROLABO OUTSOURCING Recent Developments
8.4 Minsheng
8.4.1 Minsheng Comapny Information
8.4.2 Minsheng Business Overview
8.4.3 Minsheng Atropine Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 Minsheng Atropine Product Portfolio
8.4.5 Minsheng Recent Developments
8.5 CR Double-Crane
8.5.1 CR Double-Crane Comapny Information
8.5.2 CR Double-Crane Business Overview
8.5.3 CR Double-Crane Atropine Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 CR Double-Crane Atropine Product Portfolio
8.5.5 CR Double-Crane Recent Developments
8.6 HENAN PURUI
8.6.1 HENAN PURUI Comapny Information
8.6.2 HENAN PURUI Business Overview
8.6.3 HENAN PURUI Atropine Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 HENAN PURUI Atropine Product Portfolio
8.6.5 HENAN PURUI Recent Developments
8.7 Albany Molecular Research
8.7.1 Albany Molecular Research Comapny Information
8.7.2 Albany Molecular Research Business Overview
8.7.3 Albany Molecular Research Atropine Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 Albany Molecular Research Atropine Product Portfolio
8.7.5 Albany Molecular Research Recent Developments
8.8 Alchem International
8.8.1 Alchem International Comapny Information
8.8.2 Alchem International Business Overview
8.8.3 Alchem International Atropine Sales, Price, Revenue and Gross Margin (2019-2024)
8.8.4 Alchem International Atropine Product Portfolio
8.8.5 Alchem International Recent Developments
8.9 SAURAV CHEMICALS
8.9.1 SAURAV CHEMICALS Comapny Information
8.9.2 SAURAV CHEMICALS Business Overview
8.9.3 SAURAV CHEMICALS Atropine Sales, Price, Revenue and Gross Margin (2019-2024)
8.9.4 SAURAV CHEMICALS Atropine Product Portfolio
8.9.5 SAURAV CHEMICALS Recent Developments
8.10 Katsura Chemical
8.10.1 Katsura Chemical Comapny Information
8.10.2 Katsura Chemical Business Overview
8.10.3 Katsura Chemical Atropine Sales, Price, Revenue and Gross Margin (2019-2024)
8.10.4 Katsura Chemical Atropine Product Portfolio
8.10.5 Katsura Chemical Recent Developments
8.11 Hangzhou Vega
8.11.1 Hangzhou Vega Comapny Information
8.11.2 Hangzhou Vega Business Overview
8.11.3 Hangzhou Vega Atropine Sales, Price, Revenue and Gross Margin (2019-2024)
8.11.4 Hangzhou Vega Atropine Product Portfolio
8.11.5 Hangzhou Vega Recent Developments
8.12 Wuhan senwayer century
8.12.1 Wuhan senwayer century Comapny Information
8.12.2 Wuhan senwayer century Business Overview
8.12.3 Wuhan senwayer century Atropine Sales, Price, Revenue and Gross Margin (2019-2024)
8.12.4 Wuhan senwayer century Atropine Product Portfolio
8.12.5 Wuhan senwayer century Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Atropine Value Chain Analysis
9.1.1 Atropine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Atropine Production Mode & Process
9.2 Atropine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Atropine Distributors
9.2.3 Atropine Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
LIST OF TABLES
Table 1. Atropine Industry Trends
Table 2. Atropine Industry Drivers
Table 3. Atropine Industry Opportunities and Challenges
Table 4. Atropine Industry Restraints
Table 5. Global Atropine Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 6. Global Atropine Revenue Market Share by Manufacturers (2019-2024)
Table 7. Global Atropine Sales by Manufacturers (Kg) & (2019-2024)
Table 8. Global Atropine Sales Market Share by Manufacturers
Table 9. Global Atropine Average Sales Price (USD/Kg) of Manufacturers (2019-2024)
Table 10. Global Atropine Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 11. Global Atropine Key Manufacturers Manufacturing Sites & Headquarters
Table 12. Global Atropine Manufacturers, Product Type & Application
Table 13. Global Atropine Manufacturers Commercialization Time
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Atropine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 16. Major Manufacturers of Injection
Table 17. Major Manufacturers of Drop
Table 18. Major Manufacturers of Gel
Table 19. Global Atropine Sales by Type 2019 VS 2023 VS 2030 (Kg)
Table 20. Global Atropine Sales by Type (2019-2024) & (Kg)
Table 21. Global Atropine Sales by Type (2025-2030) & (Kg)
Table 22. Global Atropine Sales Market Share by Type (2019-2024)
Table 23. Global Atropine Sales Market Share by Type (2025-2030)
Table 24. Global Atropine Revenue by Type 2019 VS 2023 VS 2030 (Kg)
Table 25. Global Atropine Revenue by Type (2019-2024) & (Kg)
Table 26. Global Atropine Revenue by Type (2025-2030) & (Kg)
Table 27. Global Atropine Revenue Market Share by Type (2019-2024)
Table 28. Global Atropine Revenue Market Share by Type (2025-2030)
Table 29. Major Manufacturers of Gastrointestinal
Table 30. Major Manufacturers of Ophthalmology
Table 31. Major Manufacturers of Other
Table 32. Global Atropine Sales by Application 2019 VS 2023 VS 2030 (Kg)
Table 33. Global Atropine Sales by Application (2019-2024) & (Kg)
Table 34. Global Atropine Sales by Application (2025-2030) & (Kg)
Table 35. Global Atropine Sales Market Share by Application (2019-2024)
Table 36. Global Atropine Sales Market Share by Application (2025-2030)
Table 37. Global Atropine Revenue by Application 2019 VS 2023 VS 2030 (Kg)
Table 38. Global Atropine Revenue by Application (2019-2024) & (Kg)
Table 39. Global Atropine Revenue by Application (2025-2030) & (Kg)
Table 40. Global Atropine Revenue Market Share by Application (2019-2024)
Table 41. Global Atropine Revenue Market Share by Application (2025-2030)
Table 42. Global Atropine Sales by Region: 2019 VS 2023 VS 2030 (Kg)
Table 43. Global Atropine Sales by Region (2019-2024) & (Kg)
Table 44. Global Atropine Sales Market Share by Region (2019-2024)
Table 45. Global Atropine Sales Forecasted by Region (2025-2030) & (Kg)
Table 46. Global Atropine Sales Forecasted Market Share by Region (2025-2030)
Table 47. North America Atropine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (Kg)
Table 48. North America Atropine Sales by Country (2019-2024) & (Kg)
Table 49. North America Atropine Sales by Country (2025-2030) & (Kg)
Table 50. Europe Atropine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (Kg)
Table 51. Europe Atropine Sales by Country (2019-2024) & (Kg)
Table 52. Europe Atropine Sales by Country (2025-2030) & (Kg)
Table 53. Asia Pacific Atropine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (Kg)
Table 54. Asia Pacific Atropine Sales by Country (2019-2024) & (Kg)
Table 55. Asia Pacific Atropine Sales by Country (2025-2030) & (Kg)
Table 56. LAMEA Atropine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (Kg)
Table 57. LAMEA Atropine Sales by Country (2019-2024) & (Kg)
Table 58. LAMEA Atropine Sales by Country (2025-2030) & (Kg)
Table 59. Global Atropine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 60. Global Atropine Revenue by Region (2019-2024) & (US$ Million)
Table 61. Global Atropine Revenue by Region (2025-2030) & (US$ Million)
Table 62. Global Atropine Revenue Market Share by Region (2019-2024)
Table 63. Global Atropine Revenue Market Share by Region (2025-2030)
Table 64. C?PHARMA Company Information
Table 65. C?PHARMA Business Overview
Table 66. C?PHARMA Atropine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 67. C?PHARMA Atropine Product Portfolio
Table 68. C?PHARMA Recent Development
Table 69. RESONANCE LABORATORIES Company Information
Table 70. RESONANCE LABORATORIES Business Overview
Table 71. RESONANCE LABORATORIES Atropine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 72. RESONANCE LABORATORIES Atropine Product Portfolio
Table 73. RESONANCE LABORATORIES Recent Development
Table 74. ROLABO OUTSOURCING Company Information
Table 75. ROLABO OUTSOURCING Business Overview
Table 76. ROLABO OUTSOURCING Atropine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 77. ROLABO OUTSOURCING Atropine Product Portfolio
Table 78. ROLABO OUTSOURCING Recent Development
Table 79. Minsheng Company Information
Table 80. Minsheng Business Overview
Table 81. Minsheng Atropine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 82. Minsheng Atropine Product Portfolio
Table 83. Minsheng Recent Development
Table 84. CR Double-Crane Company Information
Table 85. CR Double-Crane Business Overview
Table 86. CR Double-Crane Atropine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 87. CR Double-Crane Atropine Product Portfolio
Table 88. CR Double-Crane Recent Development
Table 89. HENAN PURUI Company Information
Table 90. HENAN PURUI Business Overview
Table 91. HENAN PURUI Atropine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 92. HENAN PURUI Atropine Product Portfolio
Table 93. HENAN PURUI Recent Development
Table 94. Albany Molecular Research Company Information
Table 95. Albany Molecular Research Business Overview
Table 96. Albany Molecular Research Atropine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 97. Albany Molecular Research Atropine Product Portfolio
Table 98. Albany Molecular Research Recent Development
Table 99. Alchem International Company Information
Table 100. Alchem International Business Overview
Table 101. Alchem International Atropine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 102. Alchem International Atropine Product Portfolio
Table 103. Alchem International Recent Development
Table 104. SAURAV CHEMICALS Company Information
Table 105. SAURAV CHEMICALS Business Overview
Table 106. SAURAV CHEMICALS Atropine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 107. SAURAV CHEMICALS Atropine Product Portfolio
Table 108. SAURAV CHEMICALS Recent Development
Table 109. Katsura Chemical Company Information
Table 110. Katsura Chemical Business Overview
Table 111. Katsura Chemical Atropine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 112. Katsura Chemical Atropine Product Portfolio
Table 113. Katsura Chemical Recent Development
Table 114. Hangzhou Vega Company Information
Table 115. Hangzhou Vega Business Overview
Table 116. Hangzhou Vega Atropine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 117. Hangzhou Vega Atropine Product Portfolio
Table 118. Hangzhou Vega Recent Development
Table 119. Wuhan senwayer century Company Information
Table 120. Wuhan senwayer century Business Overview
Table 121. Wuhan senwayer century Atropine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 122. Wuhan senwayer century Atropine Product Portfolio
Table 123. Wuhan senwayer century Recent Development
Table 124. Key Raw Materials
Table 125. Raw Materials Key Suppliers
Table 126. Atropine Distributors List
Table 127. Atropine Customers List
Table 128. Research Programs/Design for This Report
Table 129. Authors List of This Report
Table 130. Secondary Sources
Table 131. Primary Sources
Table 1. Atropine Industry Trends
Table 2. Atropine Industry Drivers
Table 3. Atropine Industry Opportunities and Challenges
Table 4. Atropine Industry Restraints
Table 5. Global Atropine Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 6. Global Atropine Revenue Market Share by Manufacturers (2019-2024)
Table 7. Global Atropine Sales by Manufacturers (Kg) & (2019-2024)
Table 8. Global Atropine Sales Market Share by Manufacturers
Table 9. Global Atropine Average Sales Price (USD/Kg) of Manufacturers (2019-2024)
Table 10. Global Atropine Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 11. Global Atropine Key Manufacturers Manufacturing Sites & Headquarters
Table 12. Global Atropine Manufacturers, Product Type & Application
Table 13. Global Atropine Manufacturers Commercialization Time
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Atropine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 16. Major Manufacturers of Injection
Table 17. Major Manufacturers of Drop
Table 18. Major Manufacturers of Gel
Table 19. Global Atropine Sales by Type 2019 VS 2023 VS 2030 (Kg)
Table 20. Global Atropine Sales by Type (2019-2024) & (Kg)
Table 21. Global Atropine Sales by Type (2025-2030) & (Kg)
Table 22. Global Atropine Sales Market Share by Type (2019-2024)
Table 23. Global Atropine Sales Market Share by Type (2025-2030)
Table 24. Global Atropine Revenue by Type 2019 VS 2023 VS 2030 (Kg)
Table 25. Global Atropine Revenue by Type (2019-2024) & (Kg)
Table 26. Global Atropine Revenue by Type (2025-2030) & (Kg)
Table 27. Global Atropine Revenue Market Share by Type (2019-2024)
Table 28. Global Atropine Revenue Market Share by Type (2025-2030)
Table 29. Major Manufacturers of Gastrointestinal
Table 30. Major Manufacturers of Ophthalmology
Table 31. Major Manufacturers of Other
Table 32. Global Atropine Sales by Application 2019 VS 2023 VS 2030 (Kg)
Table 33. Global Atropine Sales by Application (2019-2024) & (Kg)
Table 34. Global Atropine Sales by Application (2025-2030) & (Kg)
Table 35. Global Atropine Sales Market Share by Application (2019-2024)
Table 36. Global Atropine Sales Market Share by Application (2025-2030)
Table 37. Global Atropine Revenue by Application 2019 VS 2023 VS 2030 (Kg)
Table 38. Global Atropine Revenue by Application (2019-2024) & (Kg)
Table 39. Global Atropine Revenue by Application (2025-2030) & (Kg)
Table 40. Global Atropine Revenue Market Share by Application (2019-2024)
Table 41. Global Atropine Revenue Market Share by Application (2025-2030)
Table 42. Global Atropine Sales by Region: 2019 VS 2023 VS 2030 (Kg)
Table 43. Global Atropine Sales by Region (2019-2024) & (Kg)
Table 44. Global Atropine Sales Market Share by Region (2019-2024)
Table 45. Global Atropine Sales Forecasted by Region (2025-2030) & (Kg)
Table 46. Global Atropine Sales Forecasted Market Share by Region (2025-2030)
Table 47. North America Atropine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (Kg)
Table 48. North America Atropine Sales by Country (2019-2024) & (Kg)
Table 49. North America Atropine Sales by Country (2025-2030) & (Kg)
Table 50. Europe Atropine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (Kg)
Table 51. Europe Atropine Sales by Country (2019-2024) & (Kg)
Table 52. Europe Atropine Sales by Country (2025-2030) & (Kg)
Table 53. Asia Pacific Atropine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (Kg)
Table 54. Asia Pacific Atropine Sales by Country (2019-2024) & (Kg)
Table 55. Asia Pacific Atropine Sales by Country (2025-2030) & (Kg)
Table 56. LAMEA Atropine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (Kg)
Table 57. LAMEA Atropine Sales by Country (2019-2024) & (Kg)
Table 58. LAMEA Atropine Sales by Country (2025-2030) & (Kg)
Table 59. Global Atropine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 60. Global Atropine Revenue by Region (2019-2024) & (US$ Million)
Table 61. Global Atropine Revenue by Region (2025-2030) & (US$ Million)
Table 62. Global Atropine Revenue Market Share by Region (2019-2024)
Table 63. Global Atropine Revenue Market Share by Region (2025-2030)
Table 64. C?PHARMA Company Information
Table 65. C?PHARMA Business Overview
Table 66. C?PHARMA Atropine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 67. C?PHARMA Atropine Product Portfolio
Table 68. C?PHARMA Recent Development
Table 69. RESONANCE LABORATORIES Company Information
Table 70. RESONANCE LABORATORIES Business Overview
Table 71. RESONANCE LABORATORIES Atropine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 72. RESONANCE LABORATORIES Atropine Product Portfolio
Table 73. RESONANCE LABORATORIES Recent Development
Table 74. ROLABO OUTSOURCING Company Information
Table 75. ROLABO OUTSOURCING Business Overview
Table 76. ROLABO OUTSOURCING Atropine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 77. ROLABO OUTSOURCING Atropine Product Portfolio
Table 78. ROLABO OUTSOURCING Recent Development
Table 79. Minsheng Company Information
Table 80. Minsheng Business Overview
Table 81. Minsheng Atropine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 82. Minsheng Atropine Product Portfolio
Table 83. Minsheng Recent Development
Table 84. CR Double-Crane Company Information
Table 85. CR Double-Crane Business Overview
Table 86. CR Double-Crane Atropine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 87. CR Double-Crane Atropine Product Portfolio
Table 88. CR Double-Crane Recent Development
Table 89. HENAN PURUI Company Information
Table 90. HENAN PURUI Business Overview
Table 91. HENAN PURUI Atropine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 92. HENAN PURUI Atropine Product Portfolio
Table 93. HENAN PURUI Recent Development
Table 94. Albany Molecular Research Company Information
Table 95. Albany Molecular Research Business Overview
Table 96. Albany Molecular Research Atropine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 97. Albany Molecular Research Atropine Product Portfolio
Table 98. Albany Molecular Research Recent Development
Table 99. Alchem International Company Information
Table 100. Alchem International Business Overview
Table 101. Alchem International Atropine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 102. Alchem International Atropine Product Portfolio
Table 103. Alchem International Recent Development
Table 104. SAURAV CHEMICALS Company Information
Table 105. SAURAV CHEMICALS Business Overview
Table 106. SAURAV CHEMICALS Atropine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 107. SAURAV CHEMICALS Atropine Product Portfolio
Table 108. SAURAV CHEMICALS Recent Development
Table 109. Katsura Chemical Company Information
Table 110. Katsura Chemical Business Overview
Table 111. Katsura Chemical Atropine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 112. Katsura Chemical Atropine Product Portfolio
Table 113. Katsura Chemical Recent Development
Table 114. Hangzhou Vega Company Information
Table 115. Hangzhou Vega Business Overview
Table 116. Hangzhou Vega Atropine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 117. Hangzhou Vega Atropine Product Portfolio
Table 118. Hangzhou Vega Recent Development
Table 119. Wuhan senwayer century Company Information
Table 120. Wuhan senwayer century Business Overview
Table 121. Wuhan senwayer century Atropine Sales (Kg), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 122. Wuhan senwayer century Atropine Product Portfolio
Table 123. Wuhan senwayer century Recent Development
Table 124. Key Raw Materials
Table 125. Raw Materials Key Suppliers
Table 126. Atropine Distributors List
Table 127. Atropine Customers List
Table 128. Research Programs/Design for This Report
Table 129. Authors List of This Report
Table 130. Secondary Sources
Table 131. Primary Sources
LIST OF FIGURES
Figure 1. Atropine Product Picture
Figure 2. Global Atropine Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Atropine Market Size (2019-2030) & (US$ Million)
Figure 4. Global Atropine Sales (2019-2030) & (Kg)
Figure 5. Global Atropine Average Price (USD/Kg) & (2019-2030)
Figure 6. Global Top 5 and 10 Atropine Players Market Share by Revenue in 2023
Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Injection Picture
Figure 9. Drop Picture
Figure 10. Gel Picture
Figure 11. Global Atropine Sales by Type (2019 VS 2023 VS 2030) & (Kg)
Figure 12. Global Atropine Sales Market Share 2019 VS 2023 VS 2030
Figure 13. Global Atropine Sales Market Share by Type (2019-2030)
Figure 14. Global Atropine Revenue by Type (2019 VS 2023 VS 2030) & (Kg)
Figure 15. Global Atropine Revenue Market Share 2019 VS 2023 VS 2030
Figure 16. Global Atropine Revenue Market Share by Type (2019-2030)
Figure 17. Gastrointestinal Picture
Figure 18. Ophthalmology Picture
Figure 19. Other Picture
Figure 20. Global Atropine Sales by Application (2019 VS 2023 VS 2030) & (Kg)
Figure 21. Global Atropine Sales Market Share 2019 VS 2023 VS 2030
Figure 22. Global Atropine Sales Market Share by Application (2019-2030)
Figure 23. Global Atropine Revenue by Application (2019 VS 2023 VS 2030) & (Kg)
Figure 24. Global Atropine Revenue Market Share 2019 VS 2023 VS 2030
Figure 25. Global Atropine Revenue Market Share by Application (2019-2030)
Figure 26. North America Atropine Sales and Growth Rate (2019-2030) & (Kg)
Figure 27. North America Atropine Sales Market Share by Country (2019-2030)
Figure 28. U.S. Atropine Sales and Growth Rate (2019-2030) & (Kg)
Figure 29. Canada Atropine Sales and Growth Rate (2019-2030) & (Kg)
Figure 30. Europe Atropine Sales and Growth Rate (2019-2030) & (Kg)
Figure 31. Europe Atropine Sales Market Share by Country (2019-2030)
Figure 32. Germany Atropine Sales and Growth Rate (2019-2030) & (Kg)
Figure 33. France Atropine Sales and Growth Rate (2019-2030) & (Kg)
Figure 34. U.K. Atropine Sales and Growth Rate (2019-2030) & (Kg)
Figure 35. Italy Atropine Sales and Growth Rate (2019-2030) & (Kg)
Figure 36. Netherlands Atropine Sales and Growth Rate (2019-2030) & (Kg)
Figure 37. Asia Pacific Atropine Sales and Growth Rate (2019-2030) & (Kg)
Figure 38. Asia Pacific Atropine Sales Market Share by Country (2019-2030)
Figure 39. China Atropine Sales and Growth Rate (2019-2030) & (Kg)
Figure 40. Japan Atropine Sales and Growth Rate (2019-2030) & (Kg)
Figure 41. South Korea Atropine Sales and Growth Rate (2019-2030) & (Kg)
Figure 42. Southeast Asia Atropine Sales and Growth Rate (2019-2030) & (Kg)
Figure 43. India Atropine Sales and Growth Rate (2019-2030) & (Kg)
Figure 44. Australia Atropine Sales and Growth Rate (2019-2030) & (Kg)
Figure 45. LAMEA Atropine Sales and Growth Rate (2019-2030) & (Kg)
Figure 46. LAMEA Atropine Sales Market Share by Country (2019-2030)
Figure 47. Mexico Atropine Sales and Growth Rate (2019-2030) & (Kg)
Figure 48. Brazil Atropine Sales and Growth Rate (2019-2030) & (Kg)
Figure 49. Turkey Atropine Sales and Growth Rate (2019-2030) & (Kg)
Figure 50. GCC Countries Atropine Sales and Growth Rate (2019-2030) & (Kg)
Figure 51. Global Atropine Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 52. Global Atropine Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 53. North America Atropine Revenue (2019-2030) & (US$ Million)
Figure 54. North America Atropine Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 55. Europe Atropine Revenue (2019-2030) & (US$ Million)
Figure 56. Europe Atropine Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 57. Asia-Pacific Atropine Revenue (2019-2030) & (US$ Million)
Figure 58. Asia-Pacific Atropine Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 59. LAMEA Atropine Revenue (2019-2030) & (US$ Million)
Figure 60. LAMEA Atropine Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 61. Atropine Value Chain
Figure 62. Manufacturing Cost Structure
Figure 63. Atropine Production Mode & Process
Figure 64. Direct Comparison with Distribution Share
Figure 65. Distributors Profiles
Figure 66. Years Considered
Figure 67. Research Process
Figure 68. Key Executives Interviewed
Figure 1. Atropine Product Picture
Figure 2. Global Atropine Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Atropine Market Size (2019-2030) & (US$ Million)
Figure 4. Global Atropine Sales (2019-2030) & (Kg)
Figure 5. Global Atropine Average Price (USD/Kg) & (2019-2030)
Figure 6. Global Top 5 and 10 Atropine Players Market Share by Revenue in 2023
Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Injection Picture
Figure 9. Drop Picture
Figure 10. Gel Picture
Figure 11. Global Atropine Sales by Type (2019 VS 2023 VS 2030) & (Kg)
Figure 12. Global Atropine Sales Market Share 2019 VS 2023 VS 2030
Figure 13. Global Atropine Sales Market Share by Type (2019-2030)
Figure 14. Global Atropine Revenue by Type (2019 VS 2023 VS 2030) & (Kg)
Figure 15. Global Atropine Revenue Market Share 2019 VS 2023 VS 2030
Figure 16. Global Atropine Revenue Market Share by Type (2019-2030)
Figure 17. Gastrointestinal Picture
Figure 18. Ophthalmology Picture
Figure 19. Other Picture
Figure 20. Global Atropine Sales by Application (2019 VS 2023 VS 2030) & (Kg)
Figure 21. Global Atropine Sales Market Share 2019 VS 2023 VS 2030
Figure 22. Global Atropine Sales Market Share by Application (2019-2030)
Figure 23. Global Atropine Revenue by Application (2019 VS 2023 VS 2030) & (Kg)
Figure 24. Global Atropine Revenue Market Share 2019 VS 2023 VS 2030
Figure 25. Global Atropine Revenue Market Share by Application (2019-2030)
Figure 26. North America Atropine Sales and Growth Rate (2019-2030) & (Kg)
Figure 27. North America Atropine Sales Market Share by Country (2019-2030)
Figure 28. U.S. Atropine Sales and Growth Rate (2019-2030) & (Kg)
Figure 29. Canada Atropine Sales and Growth Rate (2019-2030) & (Kg)
Figure 30. Europe Atropine Sales and Growth Rate (2019-2030) & (Kg)
Figure 31. Europe Atropine Sales Market Share by Country (2019-2030)
Figure 32. Germany Atropine Sales and Growth Rate (2019-2030) & (Kg)
Figure 33. France Atropine Sales and Growth Rate (2019-2030) & (Kg)
Figure 34. U.K. Atropine Sales and Growth Rate (2019-2030) & (Kg)
Figure 35. Italy Atropine Sales and Growth Rate (2019-2030) & (Kg)
Figure 36. Netherlands Atropine Sales and Growth Rate (2019-2030) & (Kg)
Figure 37. Asia Pacific Atropine Sales and Growth Rate (2019-2030) & (Kg)
Figure 38. Asia Pacific Atropine Sales Market Share by Country (2019-2030)
Figure 39. China Atropine Sales and Growth Rate (2019-2030) & (Kg)
Figure 40. Japan Atropine Sales and Growth Rate (2019-2030) & (Kg)
Figure 41. South Korea Atropine Sales and Growth Rate (2019-2030) & (Kg)
Figure 42. Southeast Asia Atropine Sales and Growth Rate (2019-2030) & (Kg)
Figure 43. India Atropine Sales and Growth Rate (2019-2030) & (Kg)
Figure 44. Australia Atropine Sales and Growth Rate (2019-2030) & (Kg)
Figure 45. LAMEA Atropine Sales and Growth Rate (2019-2030) & (Kg)
Figure 46. LAMEA Atropine Sales Market Share by Country (2019-2030)
Figure 47. Mexico Atropine Sales and Growth Rate (2019-2030) & (Kg)
Figure 48. Brazil Atropine Sales and Growth Rate (2019-2030) & (Kg)
Figure 49. Turkey Atropine Sales and Growth Rate (2019-2030) & (Kg)
Figure 50. GCC Countries Atropine Sales and Growth Rate (2019-2030) & (Kg)
Figure 51. Global Atropine Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 52. Global Atropine Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 53. North America Atropine Revenue (2019-2030) & (US$ Million)
Figure 54. North America Atropine Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 55. Europe Atropine Revenue (2019-2030) & (US$ Million)
Figure 56. Europe Atropine Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 57. Asia-Pacific Atropine Revenue (2019-2030) & (US$ Million)
Figure 58. Asia-Pacific Atropine Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 59. LAMEA Atropine Revenue (2019-2030) & (US$ Million)
Figure 60. LAMEA Atropine Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 61. Atropine Value Chain
Figure 62. Manufacturing Cost Structure
Figure 63. Atropine Production Mode & Process
Figure 64. Direct Comparison with Distribution Share
Figure 65. Distributors Profiles
Figure 66. Years Considered
Figure 67. Research Process
Figure 68. Key Executives Interviewed
